Novavax (NVAX) Goodwill (2010 - 2026)

Novavax's Goodwill history runs 17 years deep, the most recent figure standing at $112.9 million for Q1 2026.

• On a quarterly basis, Goodwill rose 0.77% year-over-year to $112.9 million in Q1 2026; TTM through Mar 2026 was $112.9 million, a 0.77% increase from a year earlier, with the FY2025 full-year figure at $113.5 million, up 5.57% from the prior year.
• Goodwill declined to $112.9 million in Q1 2026 per NVAX's latest filing, from $113.5 million in the prior quarter.
• Across five years, Goodwill topped out at $130.8 million in Q1 2022 and bottomed at $107.5 million in Q4 2024.
• The 5-year median for Goodwill is $123.4 million (2024), against an average of $120.7 million.
• Across the five-year window, Goodwill decreased 15.67% in 2024 and increased 5.57% in 2025, its largest moves.
• Year by year, Goodwill stood at $126.3 million in 2022, then grew by 0.89% to $127.5 million in 2023, then declined by 15.67% to $107.5 million in 2024, then grew by 5.57% to $113.5 million in 2025, then slipped by 0.51% to $112.9 million in 2026.
• Per Business Quant, the three latest NVAX Goodwill figures stand at $112.9 million (Q1 2026), $113.5 million (Q4 2025), and $113.1 million (Q3 2025).